A Four-Year Experience of Symptomatic Intracranial Hemorrhage Rate Following Intravenous Tissue Plasminogen Activator at a Comprehensive Stroke Center (P1.086)

Jeffrey Wagner; Alessandro Orlando; Christopher Fanale; Michelle Whaley; Kathryn McCarthy; David Bar-Or

A Four-Year Experience of Symptomatic Intracranial Hemorrhage Rate Following Intravenous Tissue Plasminogen Activator at a Comprehensive Stroke Center (P1.086)

Jeffrey Wagner
, Alessandro Orlando
, Christopher Fanale
, Michelle Whaley
, Kathryn McCarthy
, David Bar-Or

2Blue Sky Neurosciences Englewood CO United States
3Swedish Medical Center Englewood CO United States
1Englewood CO United States

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neurology
Volume	84
State	Published - Apr 6 2015
Externally published	Yes

Disciplines

Medicine and Health Sciences
Pediatrics
Surgery

Cite this

@article{c0438ae6cb2e4761b2d84760b33f22af,

title = "A Four-Year Experience of Symptomatic Intracranial Hemorrhage Rate Following Intravenous Tissue Plasminogen Activator at a Comprehensive Stroke Center (P1.086)",

author = "Jeffrey Wagner and Alessandro Orlando and Christopher Fanale and Michelle Whaley and Kathryn McCarthy and David Bar-Or",

note = "OBJECTIVE: To describe the 4-year symptomatic intracranial hemorrhage (sICH) rate at a high-volume comprehensive stroke center. BACKGROUND: Treatment with tPA is beneficial in patients with ischemic stroke (IS); however, it can cause sICHs. A goal of IS treatment is to mitigate the risk of sICH, while treating the widest possible population.",

year = "2015",

month = apr,

day = "6",

language = "American English",

volume = "84",

journal = "Neurology",

}

TY - JOUR

T1 - A Four-Year Experience of Symptomatic Intracranial Hemorrhage Rate Following Intravenous Tissue Plasminogen Activator at a Comprehensive Stroke Center (P1.086)

AU - Wagner, Jeffrey

AU - Orlando, Alessandro

AU - Fanale, Christopher

AU - Whaley, Michelle

AU - McCarthy, Kathryn

AU - Bar-Or, David

N1 - OBJECTIVE: To describe the 4-year symptomatic intracranial hemorrhage (sICH) rate at a high-volume comprehensive stroke center. BACKGROUND: Treatment with tPA is beneficial in patients with ischemic stroke (IS); however, it can cause sICHs. A goal of IS treatment is to mitigate the risk of sICH, while treating the widest possible population.

PY - 2015/4/6

Y1 - 2015/4/6

UR - https://n.neurology.org/content/84/14_Supplement/P1.086.abstract

M3 - Article

VL - 84

JO - Neurology

JF - Neurology

ER -

A Four-Year Experience of Symptomatic Intracranial Hemorrhage Rate Following Intravenous Tissue Plasminogen Activator at a Comprehensive Stroke Center (P1.086)

Disciplines

Other files and links

Cite this